Table 1 from Real-World Outcomes of Elacestrant in ER+, HER2−, ESR1-Mutant Metastatic Breast Cancer

2026 Open access

Read full text
Authors: Hope S. Rugo, Virginia Kaklamani, Heather L. McArthur, Seth Andrew Wander, William John Gradishar, Reshma Mahtani, Mark Daniel Pegram, Maryam B. Lustberg, Elyse Swallow, Jessica Maitland, Sebastian Kloss, Tomer Wasserman
+1 more Sara M. Tolaney
DOI: 10.1158/1078-0432.31006797
Cited by: 0

Fields of Study & Subjects

Advanced Breast Cancer Therapies Estrogen and related hormone effects PARP inhibition in cancer therapy

Publication details

Publication date
6 January 2026